MedTrace Logo

Follow-up Studies of Primary Snoring(PS) and Obstructive Sleep Apnea Hypopnea Syndrome(OSAHS) in Chinese Children

NCT02447614 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-07-21

No results posted yet for this study

Summary

The study is designed to investigate the natural course of Primary snoring in 1-2 years or more and the different effect of drug and surgical treatment applied in children with obstructive sleep apnea (OSAS) by comparing the polysomnography(PSG) and sleep questionaires in 6 months after treatment.

Conditions

  • Obstructive Sleep Apnea Syndrome

Interventions

PROCEDURE

Adenotonsillectomy

Adenotonsillectomy

OTHER

Conservative treatment

Mometasone Furoate Aqueous Nasal Spray or uticasone propionate (1/once qd) and（or）Leukotriene antagonists(4 or 5mg/once qn) or H1 receptor antagonists

OTHER

no treatment

just regular follow-up

Sponsors & Collaborators

  • Beijing Children's Hospital

    lead OTHER

Principal Investigators

  • Xu Zhifei, MD,PhD · Beijing Children's Hospital

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2022-06-01
Completion
2022-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02447614 on ClinicalTrials.gov